Biomarkers of inflammation in infants with cystic fibrosis

[1] Pillarisetti N(2011)Australian respiratory early surveillance team for cystic fibrosis (AREST CF): infection, inflammation, and lung function decline in infants with cystic fibrosis Am J Respir Crit Care Med 184 75-81

[2] Williamson E(2012)AREST CF: progression of early structural lung disease in young children with cystic fibrosis assessed using CT Thorax 67 509-516

[3] Linnane B(2009)Australian respiratory early surveillance team for cystic fibrosis (AREST-CF): lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening Am J Respir Crit Care Med 180 146-152

[4] Skoric B(2015)Biomarkers in Paediatric cystic fibrosis lung disease Paediatr Respir Rev 16 213-218

[5] Robertson CF(1995)Early pulmonary inflammation in infants with cystic fibrosis Am J Respir Crit Care Med 151 1075-1082

[6] Robinson P(2010)Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth Sci Transl Med 2 29ra31-1970

[7] Massie J(2013)AREST CF investigators: risk factors for bronchiectasis in children with cystic fibrosis N Engl J Med 368 1963-1253

[8] Hall GL(2004)Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis J Infect Dis 190 1245-1568

[9] Sly P(2009)Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis Chest 136 1561-863

[10] Stick S(2012)Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation Pediatr Pulmonol 47 856-868

[1] Pillarisetti N(2011)Australian respiratory early surveillance team for cystic fibrosis (AREST CF): infection, inflammation, and lung function decline in infants with cystic fibrosis Am J Respir Crit Care Med 184 75-81

[2] Williamson E(2012)AREST CF: progression of early structural lung disease in young children with cystic fibrosis assessed using CT Thorax 67 509-516

[3] Linnane B(2009)Australian respiratory early surveillance team for cystic fibrosis (AREST-CF): lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening Am J Respir Crit Care Med 180 146-152

[4] Skoric B(2015)Biomarkers in Paediatric cystic fibrosis lung disease Paediatr Respir Rev 16 213-218

[5] Robertson CF(1995)Early pulmonary inflammation in infants with cystic fibrosis Am J Respir Crit Care Med 151 1075-1082

[6] Robinson P(2010)Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth Sci Transl Med 2 29ra31-1970

[7] Massie J(2013)AREST CF investigators: risk factors for bronchiectasis in children with cystic fibrosis N Engl J Med 368 1963-1253

[8] Hall GL(2004)Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis J Infect Dis 190 1245-1568

[9] Sly P(2009)Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis Chest 136 1561-863

[10] Stick S(2012)Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation Pediatr Pulmonol 47 856-868